The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...
Celestial Biologicals Limited (CBL) and GE Healthcare, the US$17 billion healthcare business of General Electric Company, announced have a collaboration to set up India’s first Good Manufacturing ...
The Insight Partners published latest research study on “Plasma Fractionation Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Product, Application, End User, and Geography,” the ...
Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Plasma Fractionation Market by Product (Immunoglobulins, Albumin, Protease Inhibitors, von Willebrand Factor ...
Newark, Oct. 17, 2023 (GLOBE NEWSWIRE) -- As per the report published by The Brainy Insights, the global Plasma Fractionation market is expected to grow from USD 28.66 Billion in 2022 to USD 49.51 ...
The global plasma fractionation market accounted for $18,222 million in 2019, and is expected to reach $23,006 million by 2027, registering a CAGR of 6.2% from 2020 to 2027. In addition, plasma ...
Grifols' Board of Directors approves a plan for new industrial investments for the Bioscience Division to ensure the company's long-term sustained growth With these new investments, Grifols increases ...
The global plasma fractionation market accounted for $18,222 million in 2019, and is expected to reach $23,006 million by 2027, registering a CAGR of 6.2% from 2020 to 2027. In addition, plasma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback